UBS analyst Danielle Antalffy reiterated a Sell rating and $105.00 price target on Zimmer Biomet (NYSE: ZBH).The analyst commented, "ZBH ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE